urotensin II receptor antagonists (Johnson & Johnson)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameurotensin II receptor antagonists (Johnson & Johnson)
Drug Alias NameJNJ-39327041JNJ-39319202JNJ-38745902
ClassificationSmall molecules
Mechanisms of ActionUrotensin II receptor antagonists
TargetsUrotensin II receptor
Therapy Area/IndicationsMetabolic DiseasesCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A